Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01808131 · ClinicalTrials.gov registry record · Phase 3
Lesinurad and Allopurinol Combination Extension Study in Gout
A Phase 3 study, sponsored by Ardea Biosciences.
- Completed
- Registry status
- Phase 3
- Development phase
- 717
- Enrollment target
NCT01808131 is a Phase 3 study that has completed, run by Ardea Biosciences. The registered enrollment target is 717 participants.
The verdict
NCT01808131, a Phase 3 study, has completed, sponsored by Ardea Biosciences.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 717 participants
- Enrollment target
Study Summary
This study will assess the serum uric acid lowering effects and safety of lesinurad in combination with allopurinol over a long-term timeframe.
Interventions
- DRUG Lesinurad
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 717 participants |
| Start Date | 2013-02 |
| Est. Completion | 2016-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01808131
The ClinicalTrials.gov registry entry for NCT01808131 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 717 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ardea Biosciences, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lesinurad is the first listed.
NCT01808131 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01808131 about?
NCT01808131 is a clinical study titled "Lesinurad and Allopurinol Combination Extension Study in Gout". This study will assess the serum uric acid lowering effects and safety of lesinurad in combination with allopurinol over a long-term timeframe.
What is the current status of trial NCT01808131?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 717 participants. The study started on 2013-02. Estimated completion is 2016-11.
What interventions are being tested in trial NCT01808131?
The interventions under investigation include: Lesinurad (DRUG).
Who is sponsoring clinical trial NCT01808131?
This trial is sponsored by Ardea Biosciences, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.